| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Histology and Embryology,* Molecular Carcinogenesis Group, School of Medicine, University of Athens, Athens, Greece; the Departments of Pharmacology, Biochemistry, and General Biology, ¶ School of Medicine, University of Patras, Patras, Greece; and the Department of Molecular Biology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan
Replication licensing ensures once per cell cycle replication and is essential for genome stability. Overexpression of two key licensing factors, Cdc6 and Cdt1, leads to overreplication and chromosomal instability (CIN) in lower eukaryotes and recently in human cell lines. In this report, we analyzed hCdt1, hCdc6, and hGeminin, the hCdt1 inhibitor expression, in a series of non-small-cell lung carcinomas, and investigated for putative relations with G1/S phase regulators, tumor kinetics, and ploidy. This is the first study of these fundamental licensing elements in primary human lung carcinomas. We herein demonstrate elevated levels (more than fourfold) of hCdt1 and hCdc6 in 43% and 50% of neoplasms, respectively, whereas aberrant expression of hGeminin was observed in 49% of cases (underexpression, 12%; overexpression, 37%). hCdt1 expression positively correlated with hCdc6 and E2F-1 levels (P = 0.001 and P = 0.048, respectively). Supportive of the observed link between E2F-1 and hCdt1, we provide evidence that E2F-1 up-regulates the hCdt1 promoter in cultured mammalian cells. Interestingly, hGeminin overexpression was statistically related to increased hCdt1 levels (P = 0.025). Regarding the kinetic and ploidy status of hCdt1- and/or hCdc6-overexpressing tumors, p53-mutant cases exhibited significantlyincreased tumor growth values (Growth Index; GI) and aneuploidy/CIN compared to those bearing intact p53 (P = 0.008 for GI, P = 0.001 for CIN). The significance of these results was underscored by the fact that the latter parameters were independent of p53 within the hCdt1-hCdc6 normally expressing cases. Cumulatively, the above suggest a synergistic effect between hCdt1-hCdc6 overexpression and mutant-p53 over tumor growth and CIN in non-small-cell lung carcinomas.
This article has been cited by other articles:
 |
|
 |
|
  J. K. Teer and A. Dutta Human Cdt1 Lacking the Evolutionarily Conserved Region That Interacts with MCM2-7 Is Capable of Inducing Re-replication J. Biol. Chem., March 14, 2008; 283(11): 6817 - 6825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Borlado and J. Mendez CDC6: from DNA replication to cell cycle checkpoints and oncogenesis Carcinogenesis, February 1, 2008; 29(2): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lau, T. Tsuji, L. Guo, S.-H. Lu, and W. Jiang The role of pre-replicative complex (pre-RC) components in oncogenesis FASEB J, December 1, 2007; 21(14): 3786 - 3794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Liontos, M. Koutsami, M. Sideridou, K. Evangelou, D. Kletsas, B. Levy, A. Kotsinas, O. Nahum, V. Zoumpourlis, M. Kouloukoussa, et al. Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior Cancer Res., November 15, 2007; 67(22): 10899 - 10909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y.-L. Lee, E. Liu, and X. Wu The Mre11/Rad50/Nbs1 Complex Plays an Important Role in the Prevention of DNA Rereplication in Mammalian Cells J. Biol. Chem., November 2, 2007; 282(44): 32243 - 32255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Lin and A. Dutta ATR Pathway Is the Primary Pathway for Activating G2/M Checkpoint Induction After Re-replication J. Biol. Chem., October 19, 2007; 282(42): 30357 - 30362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hall, E. Kow, K. R. Nevis, C. K. Lu, K. S. Luce, Q. Zhong, and J. G. Cook Cdc6 Stability Is Regulated by the Huwe1 Ubiquitin Ligase after DNA Damage Mol. Biol. Cell, September 1, 2007; 18(9): 3340 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, B. Larris, T. H. Peiris, L. Zhang, J. Le Lay, Y. Gao, and L. E. Greenbaum C/EBPbeta Activates E2F-regulated Genes in Vivo via Recruitment of the Coactivator CREB-binding Protein/P300 J. Biol. Chem., August 24, 2007; 282(34): 24679 - 24688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Weisz, A. Damalas, M. Liontos, P. Karakaidos, G. Fontemaggi, R. Maor-Aloni, M. Kalis, M. Levrero, S. Strano, V. G. Gorgoulis, et al. Mutant p53 Enhances Nuclear Factor {kappa}B Activation by Tumor Necrosis Factor {alpha} in Cancer Cells Cancer Res., March 15, 2007; 67(6): 2396 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Arias and J. C. Walter Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells Genes & Dev., March 1, 2007; 21(5): 497 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Machida and A. Dutta The APC/C inhibitor, Emi1, is essential for prevention of rereplication Genes & Dev., January 15, 2007; 21(2): 184 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hu and Y. Xiong An Evolutionarily Conserved Function of Proliferating Cell Nuclear Antigen for Cdt1 Degradation by the Cul4-Ddb1 Ubiquitin Ligase in Response to DNA Damage J. Biol. Chem., February 17, 2006; 281(7): 3753 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. May, M. Thomer, K. F. Murnen, and B. R. Calvi Levels of the origin-binding protein Double parked and its inhibitor Geminin increase in response to replication stress J. Cell Sci., September 15, 2005; 118(18): 4207 - 4217. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
